First Long Island Investors LLC Reduces Position in Intuitive Surgical, Inc. $ISRG

Key Points

• First Long Island Investors LLC reduced its stake in Intuitive Surgical, Inc. by 14.7%, now owning 11,600 shares valued at approximately $5.74 million after selling 2,000 shares in the first quarter.
• Institutional investors hold 83.64% of Intuitive Surgical's stock, with several hedge funds increasing their positions in the company during the latest reporting periods.
• Analysts generally maintain a "Moderate Buy" rating on Intuitive Surgical, with a consensus price target of $595.95, although a few have issued more conservative ratings.

First Long Island Investors LLC decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 14.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,600 shares of the medical equipment provider's stock after selling 2,000 shares during the period. First Long Island Investors LLC's holdings in Intuitive Surgical were worth $5,745,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the stock. AlphaCore Capital LLC boosted its holdings in shares of Intuitive Surgical by 4.2% during the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after purchasing an additional 18 shares during the last quarter. Second Line Capital LLC boosted its holdings in shares of Intuitive Surgical by 3.4% during the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after purchasing an additional 19 shares during the last quarter. Crown Wealth Group LLC boosted its holdings in shares of Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after purchasing an additional 20 shares during the last quarter. FSM Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical by 3.8% during the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock worth $270,000 after purchasing an additional 20 shares during the last quarter. Finally, CFO4Life Group LLC boosted its holdings in shares of Intuitive Surgical by 4.8% during the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider's stock worth $216,000 after purchasing an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Citigroup restated a "buy" rating and set a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Zacks Research cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Royal Bank Of Canada restated an "outperform" rating and set a $615.00 price objective on shares of Intuitive Surgical in a report on Tuesday, August 19th. Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Finally, UBS Group boosted their price target on Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a research report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $595.95.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of the business's stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director owned 1,074 shares in the company, valued at $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 over the last quarter. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Up 1.3%

ISRG stock opened at $455.85 on Friday. The stock has a 50-day moving average price of $487.55 and a two-hundred day moving average price of $509.57. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The company has a market cap of $163.41 billion, a PE ratio of 63.58, a price-to-earnings-growth ratio of 4.72 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm's quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.78 earnings per share. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.